NATICK, Mass., June 15, 2021 /PRNewswire/ — AffyImmune Therapeutics, Inc., a clinical stage biotechnology company developing safe, effective ways to use CAR T cells against solid cancers, announced today the addition of Dr. Jim Mulé to its Scientific Advisory Board to provide strategic guidance for its scientific programs. He joins Dr. Keith Knutson, Professor of Immunology at the Mayo Clinic, and Dr. Cassian Yee, Professor of Melanoma Medical Oncology and Immunology at MD Anderson and Director of the Solid Tumor Cell Therapy Program. “We are very pleased to welcome Dr. Mulé to our Scientific Advisory Board,” said Moonsoo Jin, scientific … Continue reading AffyImmune Therapeutics Announces Addition of Dr. Jim Mulé to its Scientific Advisory Board